Paige designed this ground-breaking study to understand how assistance from Paige Prostate Detect, an AI that aids in the detection of prostate cancers, could impact pathologist performance.
The study’s outcomes were pivotal in Paige Prostate Detect ultimately receiving the first FDA-approval for an AI in pathology
The study found that:
- Paige Prostate Detect reduced cancer detection errors by 70%
- Statistically significant sensitivity gains were seen among non-GU pathologists and GU pathologists
